Published in J Interv Card Electrophysiol on December 01, 2007
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 23.22
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 6.68
Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation (2000) 6.56
The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg (1991) 4.53
Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation (1999) 4.00
Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation (2003) 3.99
Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol (2001) 3.83
Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation (2004) 3.44
A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg (2004) 2.95
The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg (2003) 2.82
Epicardial mapping of chronic atrial fibrillation in patients: preliminary observations. Circulation (2004) 2.29
Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation (2003) 2.17
A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation (2006) 1.98
Successful surgical treatment of atrial fibrillation. Review and clinical update. JAMA (1991) 1.89
Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart Rhythm (2005) 1.84
Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function. Heart Rhythm (2005) 1.70
Chronic transmural atrial ablation by using bipolar radiofrequency energy on the beating heart. J Thorac Cardiovasc Surg (2002) 1.63
Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation (2006) 1.63
The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg (2000) 1.37
Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation. Circulation (2006) 1.37
A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. Ann Surg (2006) 1.26
Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veins: a chronic animal study. Ann Thorac Surg (2003) 1.26
Totally endoscopic ablation of lone atrial fibrillation: initial clinical experience. Ann Thorac Surg (2006) 1.20
Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients. Circulation (2005) 1.14
A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillation: early results. Ann Thorac Surg (2004) 1.11
Progress in nonpharmacologic therapy of atrial fibrillation. J Cardiovasc Electrophysiol (2003) 1.05
Spatial and temporal stability of the dominant frequency of activation in human atrial fibrillation. J Electrocardiol (2006) 1.02
Three years experience with monopolar and bipolar radiofrequency ablation surgery in patients with permanent atrial fibrillation. Eur J Cardiothorac Surg (2005) 0.86
Surgery for atrial fibrillation. Ann Thorac Cardiovasc Surg (2005) 0.84
Long-term results of cryoablation with a new cryoprobe to eliminate chronic atrial fibrillation associated with mitral valve disease. Pacing Clin Electrophysiol (2005) 0.80
POINT: Prosthesis-patient mismatch does not affect survival for patients greater than 70 years of age undergoing bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg (2008) 3.10
A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg (2004) 2.95
The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg (2003) 2.82
Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation (2010) 2.57
Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg (2007) 2.22
Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure. J Thorac Cardiovasc Surg (2008) 2.22
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Early stenosis of Medtronic Mosaic porcine valves in the aortic position. J Thorac Cardiovasc Surg (2008) 2.05
Atrial fibrillation propagates through gaps in ablation lines: implications for ablative treatment of atrial fibrillation. Heart Rhythm (2008) 1.87
Microwave ablation for atrial fibrillation: dose-response curves in the cardioplegia-arrested and beating heart. Ann Thorac Surg (2006) 1.83
The cox-maze procedure for lone atrial fibrillation: a single-center experience over 2 decades. Circ Arrhythm Electrophysiol (2011) 1.79
Epicardial microwave ablation on the beating heart for atrial fibrillation: the dependency of lesion depth on cardiac output. J Thorac Cardiovasc Surg (2006) 1.73
Chronic transmural atrial ablation by using bipolar radiofrequency energy on the beating heart. J Thorac Cardiovasc Surg (2002) 1.63
Maintenance of myocyte volume homeostasis during stress by diazoxide is cardioprotective. Ann Thorac Surg (2007) 1.63
Surgical treatment of atrial fibrillation: predictors of late recurrence. J Thorac Cardiovasc Surg (2005) 1.61
Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation (2005) 1.59
Risk factors for leg harvest surgical site infections after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg (2003) 1.51
Successful management of unremitting spasm of the nongrafted right coronary artery after off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg (2007) 1.51
Radial artery grafts in women: utilization and results. Ann Thorac Surg (2005) 1.48
Deterioration and mortality among patients with United Network for Organ Sharing status 2 heart disease: caution must be exercised in diverting organs. J Thorac Cardiovasc Surg (2006) 1.45
Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg (2007) 1.43
The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis. J Thorac Cardiovasc Surg (2007) 1.43
Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg (2011) 1.41
Spontaneous atrioventricular groove disruption during off-pump coronary artery bypass grafting. Ann Thorac Surg (2005) 1.39
Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg (2011) 1.30
The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J Interv Card Electrophysiol (2011) 1.30
Aortic enlargement and late reoperation after repair of acute type A aortic dissection. Ann Thorac Surg (2007) 1.29
Atrial tachyarrhythmias after the maze procedure: incidence and prognosis. Circulation (2004) 1.29
A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. Ann Surg (2006) 1.26
Physiological consequences of bipolar radiofrequency energy on the atria and pulmonary veins: a chronic animal study. Ann Thorac Surg (2003) 1.26
Efficacy and safety of right and left atrial ablations on the beating heart with irrigated bipolar radiofrequency energy: a long-term animal study. J Thorac Cardiovasc Surg (2006) 1.25
Repair of ischemic mitral regurgitation does not increase mortality or improve long-term survival in patients undergoing coronary artery revascularization: a propensity analysis. Ann Thorac Surg (2004) 1.23
The effect of robotic assistance on learning curves for basic laparoscopic skills. Am J Surg (2002) 1.21
Importance of geometry and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis. Circulation (2005) 1.19
Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg (2008) 1.19
Evaluation of a novel cryoablation system: in vivo testing in a chronic porcine model. Innovations (Phila) (2013) 1.17
Animal studies of epicardial atrial ablation. Heart Rhythm (2009) 1.17
The impact of CHADS2 score on late stroke after the Cox maze procedure. J Thorac Cardiovasc Surg (2012) 1.16
Bartonella species-induced prosthetic valve endocarditis associated with rapid progression of valvular stenosis. J Thorac Cardiovasc Surg (2005) 1.15
Surgical experience with cardiac papillary fibroelastoma over a 15-year period. Ann Thorac Surg (2012) 1.14
Cox-Maze IV results for patients with lone atrial fibrillation versus concomitant mitral disease. Ann Thorac Surg (2012) 1.13
Aortic valve replacement in octogenarians: risk factors for early and late mortality. Ann Thorac Surg (2007) 1.13
Use of an apical heart suction device for exposure in lung transplantation. Ann Thorac Surg (2006) 1.13
A prospective multicenter trial of bipolar radiofrequency ablation for atrial fibrillation: early results. Ann Thorac Surg (2004) 1.11
Evaluation of a novel cryoablation system: in vitro testing of heat capacity and freezing temperatures. Innovations (Phila) (2013) 1.09
Noninvasive electrocardiographic imaging (ECGI) of scar-related atypical atrial flutter. Heart Rhythm (2007) 1.09
Hyperkalemic cardioplegia-induced myocyte swelling and contractile dysfunction: prevention by diazoxide. Ann Thorac Surg (2006) 1.07
The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. J Thorac Cardiovasc Surg (2011) 1.06
Surgical ablation devices for atrial fibrillation. J Interv Card Electrophysiol (2007) 1.05
Importance of blood pressure control after repair of acute type a aortic dissection: 25-year follow-up in 252 patients. J Clin Hypertens (Greenwich) (2012) 1.03
Spatial and temporal stability of the dominant frequency of activation in human atrial fibrillation. J Electrocardiol (2006) 1.02
Prosthesis-patient mismatch after aortic valve replacement: impact of age and body size on late survival. Ann Thorac Surg (2006) 1.02
Successful performance of Cox-Maze procedure on beating heart using bipolar radiofrequency ablation: a feasibility study in animals. Ann Thorac Surg (2004) 1.02
Epicardial Ablation on the Beating Heart: Limited Efficacy of a Novel, Cooled Radiofrequency Ablation Device. Innovations (Phila) (2009) 1.02
Surgical ablation for atrial fibrillation: the efficacy of a novel bipolar pen device in the cardioplegically arrested and beating heart. J Thorac Cardiovasc Surg (2008) 1.01
Chronic performance of a novel radiofrequency ablation device on the beating heart: Limitations of conduction delay to assess transmurality. J Thorac Cardiovasc Surg (2012) 1.01
Myocyte volume and function in response to osmotic stress: observations in the presence of an adenosine triphosphate-sensitive potassium channel opener. Circulation (2005) 1.01
The effects of the Cox maze procedure on atrial function. J Thorac Cardiovasc Surg (2008) 1.01
Outcomes of tricuspid valve repair and replacement: a propensity analysis. Ann Thorac Surg (2009) 1.00
Vagal denervation and reinnervation after ablation of ganglionated plexi. J Thorac Cardiovasc Surg (2009) 0.99
Role of the sarcolemmal adenosine triphosphate-sensitive potassium channel in hyperkalemic cardioplegia-induced myocyte swelling and reduced contractility. Ann Thorac Surg (2006) 0.99
Impact of complete revascularization on long-term survival after coronary artery bypass grafting in octogenarians. Ann Thorac Surg (2005) 0.99
Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center. Semin Thorac Cardiovasc Surg (2004) 0.96
Our surgical culture of blame: a time for change. J Thorac Cardiovasc Surg (2003) 0.96
Comparison of skill training with robotic systems and traditional endoscopy: implications on training and adoption. J Surg Res (2005) 0.95
What is the best way to surgically eliminate the left atrial appendage? J Am Coll Cardiol (2008) 0.94
Diazoxide maintains human myocyte volume homeostasis during stress. J Am Heart Assoc (2012) 0.94
A minimally invasive cox-maze procedure: operative technique and results. Innovations (Phila) (2012) 0.94
Does functional mitral regurgitation improve with isolated aortic valve replacement? J Card Surg (2004) 0.93
Alternative energy sources for atrial ablation: judging the new technology. Ann Thorac Surg (2003) 0.93
Efficacy of a novel bipolar radiofrequency ablation device on the beating heart for atrial fibrillation ablation: a long-term porcine study. J Thorac Cardiovasc Surg (2010) 0.93
Elective surgery for thoracic aortic aneurysms: late functional status and quality of life. Ann Thorac Surg (2006) 0.92
Surgical robotics: impact of motion scaling on task performance. J Am Coll Surg (2004) 0.91
Ablation technology for the surgical treatment of atrial fibrillation. ASAIO J (2013) 0.91
Clostridium difficile in cardiac surgery: risk factors and impact on postoperative outcome. Ann Thorac Surg (2007) 0.90
Radial artery patency: are aortocoronary conduits superior to composite grafting? Ann Thorac Surg (2003) 0.89
Mechanical support for isolated right ventricular failure in patients after cardiotomy. J Heart Lung Transplant (2004) 0.88
The surgical treatment of atrial fibrillation. Heart Rhythm (2009) 0.88
Failure of medical therapy for pulmonary "thromboembolic" disease: beware the unsuspected primary sarcoma of the pulmonary artery. J Thorac Cardiovasc Surg (2004) 0.88
The surgical treatment of atrial fibrillation. Surg Clin North Am (2009) 0.88
Nesiritide (BNP) in the management of postoperative cardiac patients. Ann Thorac Surg (2003) 0.87
Evaluation of revascularization subtypes in octogenarians undergoing coronary artery bypass grafting. Circulation (2009) 0.87
Epicardial ablation on the beating heart: progress towards an off-pump maze procedure. Heart Surg Forum (2002) 0.85
Management of arterial injuries caused by laser extraction of indwelling venous pacemaker and defibrillator leads. Pacing Clin Electrophysiol (2006) 0.84
NORMAL QUALITY OF LIFE AFTER THE COX MAZE PROCEDURE FOR ATRIAL FIBRILLATION. Innovations (Phila) (2008) 0.84
Robotics in cardiac surgery: the Emperor's new clothes. J Thorac Cardiovasc Surg (2007) 0.83
Differential impact of short periods of rapid atrial pacing on left and right atrial mechanical function. Am J Physiol Heart Circ Physiol (2012) 0.83
Surgical techniques used for the treatment of atrial fibrillation. Circ J (2013) 0.83
Mortality associated with bloodstream infection after coronary artery bypass surgery. Clin Infect Dis (2008) 0.83
Importance of atrial surface area and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis. J Thorac Cardiovasc Surg (2012) 0.83
Predictors and risk of pacemaker implantation after the Cox-maze IV procedure. Ann Thorac Surg (2013) 0.82
Surgical treatment of atrial fibrillation. Mo Med (2012) 0.81
Donor heart preservation with pinacidil: the role of the mitochondrial K ATP channel. Ann Thorac Surg (2004) 0.81
Flow dynamics of the internal thoracic and radial artery T-graft. Ann Thorac Surg (2004) 0.81
Wide variations in energy delivery using an impedance-controlled algorithm in bipolar radiofrequency ablation: evidence against fixed time ablation. Innovations (Phila) (2007) 0.80
Images in cardiovascular medicine. Left ventricular apical pseudoaneurysm: echocardiographic and intraoperative findings. Circulation (2002) 0.80